It's almost time! Know Your NETs starts TODAY at 11 AM ET!
Join the livestream for our largest #neuroendocrinecancer patient and caregiver conference of the year.
➡️ow.ly/pgvN50ZpaZv
🚨Attention #Neuroendocrinecancer researchers: NETRF has just launched its first Early Detection Request for Applications (RFA).
Letters of Intent (LOIs) Due: Monday, June 15, 2026, 5 PM ET
Learn more ➡️ ow.ly/kQl750Z1a8B
➡️ EP-NEC patients require expert care from specialists knowledgeable in #neuroendocrine carcinoma
➡️ Generic care is insufficient to address the aggressive nature and unique challenges of this disease
What else do HCPs need to know to support pts w/ extrapulmonary neuroendocrine carcinoma?
📺 Watch the video to find out
From Jessica Thomas, Director of Patient Education at the Neuroendocrine Tumor Research Foundation
🤝Endorsed by @CureNETs & Minkahz NETs Mission
See more of this programme: cor2ed.com/net-connect/progr…
Supported by an Independent Educational Grant from Boehringer Ingelheim
#MedEd#OncTwitter
University of Michigan researchers @yuanyuan_qiao and @ArulChinnaiyan have identified a new target that can suppress tumor growth in gastroenteropancreatic neuroendocrine tumors.
Learn how their findings can be used to develop new treatment methods: michmed.org/VdBz7.
Tijana Jovanovic-Talisman, PhD, is among this year's NETRF Pilot Award grantees, and her work to improve diagnostics for #neuroendocrinecancer is deeply personal.
Read more: ow.ly/jZHS50YyMjJ#NETRFGrantee
Congratulations to Chiara Mazziotta, PhD, of @DanaFarber on her NETRF Mentored Research Award for her research on Merkel cell carcinoma, a rare neuroendocrine skin cancer.
Learn more about Dr. Mazziotta’s research: ow.ly/MrqO50YuXuZ#NETRFGrantee#Merkelcellcarcinoma